Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial - Wikidata - awgldk - TriplyDB

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

http://www.wikidata.org/entity/Q28552031

about

Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine.

P2860

Q37097177-8C716918-B2AD-4037-981C-E9A4CC3FF6F5 Q37108386-2F181864-7AB8-4A43-AEFE-40561E2EBAC7 Q37613241-7BF0B69F-9E26-4199-8F87-D24A64E2238B Q40375985-3193CA9D-C8DF-46A8-A67C-26633FA8ADBC Q50027688-BC99D628-8304-4D3C-8DF8-93AF85EA2206

P2860

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

http://www.wikidata.org/entity/Q28552031

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@ast

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@en

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@nl

type

label

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@ast

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@en

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@nl

prefLabel

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@ast

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@en

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@nl

P1433

Q28552031-3BD19515-E9FF-4A06-BFF1-B800F5EFD086

P1476

Q28552031-30208090-59D6-4F74-9AD3-6AF33BCEBC12

P2093

Q28552031-01FDF0AE-DBD0-46FD-91BB-B8346C51F73F

Q28552031-0B5D36A2-9523-415A-9726-C22FF5186870

Q28552031-141B6389-4F20-449F-8B3A-8A03B8ACDD4C

Q28552031-5CDF7AAE-F746-401D-BF2B-7FEF8D320E2D

Q28552031-73661B34-B10F-4A6F-92AB-E7ACB0D16AC6

Q28552031-EFD0417C-39F4-4E68-989A-A920FA154B93

P2860

Q28552031-01E95EC9-0DBD-4AF5-8D13-8B0E6D064CE6

Q28552031-145A0A65-8694-4867-B372-79AAD2982890

Q28552031-1B3EFE24-F98A-4B91-A2FD-CCE9974542DF

Q28552031-1C885166-FE22-4A28-8E00-53BD84299253

Q28552031-234FD366-C60F-43F9-BCBD-4681F3CDE842

Q28552031-305500E1-747A-47B3-B980-2E048BB80B1A

Q28552031-327BE1C8-8A12-4F69-A761-85EB1E113CE1

Q28552031-44593A97-82ED-4476-AE7A-D3CA9F08074B

Q28552031-48D7F2C1-0AF8-4B29-A178-A14883EDE2D0

Q28552031-56494564-8D53-441F-8786-0AD7C98620FE

P304

Q28552031-B48B63F5-5355-4F90-8717-DC77EB696997

P31

Q28552031-455755E3-6889-4A9D-827B-5EF7117DC0D0

P3181

Q28552031-30F784BE-D69B-41D8-802C-454892D4AAE6

P356

Q28552031-140ACB44-952D-43D0-A5A5-DCDAD127C79D

P407

Q28552031-0CB3CFD1-D7F3-461E-99B0-8E9CCDAA1720

P433

Q28552031-D7EE1B46-383B-4948-882D-FA4AD2FD2122

P478

Q28552031-7C8DE9C5-A8B7-4FB1-A063-357DD89FEDD8

P50

Q28552031-779A3E8E-CAB0-4DEB-85BB-5276AA83D8D6

P577

Q28552031-155386CD-720B-41E1-BE76-445B71CE7ABC

P5875

Q28552031-3394B20C-2AC8-43CE-8171-3693EA3A6C23

P698

Q28552031-86DA8F07-5F74-47F9-9465-4030FB64D9CC

P921

Q28552031-194687A9-671E-4721-9498-2A1F25ABA72A

Q28552031-BE9E8F1C-1887-4257-A672-A6D26ACF8DA6

P932

Q28552031-4E54BF05-3827-4468-9229-E5ABEEDBAF9D

P3181

P356

JOURNAL.PMED.1001934

P1433

P1476

Cotrimoxazole Prophylaxis Disc ...... ndomized Non-inferiority Trial

@en

P2093

Barbra A Richardson

http://www.w3.org/2001/XMLSchema#string

Benson Singa

http://www.w3.org/2001/XMLSchema#string

Christina S Polyak

http://www.w3.org/2001/XMLSchema#string

Judd Walson

http://www.w3.org/2001/XMLSchema#string

Krista Yuhas

http://www.w3.org/2001/XMLSchema#string

Monica Khaemba

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.

Water filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members.

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.

Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up

HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

P304

e1001934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

59302

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001934

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Grace John-Stewart

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289489167

http://www.w3.org/2001/XMLSchema#string

P698

26731191

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4701407

http://www.w3.org/2001/XMLSchema#string